Zach Zhu
Chief Technology Officer Innorna
Zach is Chief Technology Officer at Innorna, leading the company’s CMC division. With over 15 years in biotech and biopharma, he brings deep expertise in process development, technology transfer, and manufacturing. Previously, he was Senior Director and Head of Drug Product at Iveric Bio (an Astellas company). He also held roles at Moderna, Biogen, and Bristol Myers Squibb earlier in his career. Zach earned his Ph.D. in Biochemistry from the University of Notre Dame, and his M.S. and B.S. in Chemistry from Nanjing University.
Seminars
Saturday 29th August 2026
Engineering Targeted mRNA LNPs to Enable In Vivo Immunotherapy for Autoimmune Diseases
11:30 am
- NHP data demonstrating the potential of targeted mRNA LNPs to enable in vivo immunotherapy for autoimmune disease models
- Robust B-cell depletion across peripheral blood, spleen, and lymphoid tissues using a proprietary targeted LNP delivery platform
- Evidence of immune reset biology with emerging safety and tolerability supporting continued preclinical development
